...to figure out in the coming months and years, there is now a stronger likelihood that marijuana will make its way more into workers’ comp on some level or another....
...to figure out in the coming months and years, there is now a stronger likelihood that marijuana will make its way more into workers’ comp on some level or another....
...comp claim populations are due to a combination of factors and efforts at federal, state, and individual program levels championed by workers’ compensation payers and PBMs. As we have seen...
...device-enabled communication can augment it by providing more touchpoints in the workers’ comp journey, allowing injured workers to engage in their care by communicating directly with claims teams. This digital...
...Pharmacy considerations for claims with cardiovascular comorbidities An expert Q&A on cybersecurity threats in workers’ comp Population considerations for Gen Z workers Drug classes driving pharmacy spend in workers’ comp...
...non-pharmaceutical approaches, big data and advanced analytics, and smart technology. Insight 1 –Engaging Patients for Healthier Lifestyles On the patient engagement front, several trends radiate around employee wellness. With comp...
...comp, and as a new brand drug may incur higher costs when generic medications are readily available. According to the FDA-approved drug label, Combogesic features similar warnings that respectively come...
...the impact of comorbidities has been well documented, including findings that claims with comorbidities have medical costs that are double those of similar claims without a comorbidity diagnosis.3 Comorbidities and...
...safety test results and other critical information with the U.S. government The Department of Commerce will develop standards and best practices for detecting AI-generated content and authenticating official content to...
With four years having passed since the Centers for Disease Control and Prevention (CDC) published their Guideline for Prescribing Opioids for Chronic Pain, the CDC recently opened up a comment period...
...cannabis use disorder. The numbers reported by JAMA are liable to change in the coming years, as access to medications for OUD, such as buprenorphine, could increase. Efforts from a...